Effective mosquito control is vital to curtail the devastating health effects of many vectored diseases. RNA interference (RNAi)-mediated control of mosquitoes is an attractive alternative to conventional chemical pesticides. Previous studies have suggested that transcripts for inhibitors of apoptosis (IAPs) may be good RNAi targets. To revisit and extend previous reports, we examined the expression of Aedes aegypti (L.) IAPs (AaeIAPs) 1, 2, 5, 6, 9, and a viral IAP-associated factor (vIAF) as well as Anopheles quadrimaculatus Say and Culex quinquefasciatus Say IAP1 homologs (AquIAP1 and CquIAP1) in adult females. Expression profiles of IAPs suggested that some older female mosquitoes had significantly higher IAP mRNA levels when compared to the youngest ones. Minor differences in expression of AaeIAPs were observed in mosquitoes that imbibed a bloodmeal, but the majority of the time points (up to 48 h) were not significantly different. Although in vitro experiments with the Ae. aegypti Aag-2 cell line demonstrated that the various AaeIAPs could be effectively knocked down within one day after dsRNA treatment, only Aag-2 cells treated with dsIAP1 displayed apoptotic morphology. Gene silencing and mortality were also evaluated after topical application and microinjection of the same dsRNAs into female Ae. aegypti. In contrast to previous reports, topical administration of dsRNA against AaeIAP1 did not yield a significant reduction in gene expression or increased mortality. Knockdown of IAP1 and other IAPs by microinjection did not result in significant mortality. In toto, our findings suggest that IAPs may not be suitable RNAi targets for controlling adult mosquito populations.
specific genes that may potentially reduce fitness and/or cause mortality in mosquitoes. Examples of possible molecular targets include AeSCP-2 (Blitzer et al. 2005) , vATPase (Coy et al. 2012) , COPI (Isoe et al. 2011 ), and apoptotic-related genes (Pridgeon et al. 2008a, Wang and .
Apoptosis, or programmed cell death, is a cellular mechanism that is important in embryonic development, tissue homeostasis, and normal functioning of the immune system (Elmore 2007; Taylor et al. 2008) . Changes commonly associated with apoptotic cells include cell shrinkage and blebbing, cell detachment from the substratum, chromatin condensation, and chromosomal DNA fragmentation (Saraste and Pulkki 2000) . Apoptosis is highly regulated and governed by a variety of Bcl-2 proteins, caspases, and inhibitors of apoptosis (IAPs) that either promote or inhibit cell suicide. Moreover, apoptosis is an evolutionarily conserved process, with homologous genes discovered in a plethora of different organisms (e.g., nematodes, insects, mammals). Apoptosis has been extensively studied in Drosophila (Hay 2000 , Kornbluth and White 2005 , Steller 2008 ), but is not as well-characterized in other arthropods. However, several genes have been identified in mosquitoes that share sequence homology with genes in the core apoptosis pathway of D. melanogaster.
Several studies in Ae. aegypti have identified and characterized apoptosis-related genes (Bryant et al. 2008 , Liu and Clem 2011 , Wang and Clem 2011 . Some of these studies have examined the IAP family of anti-apoptotic genes, which encode cellular proteins with baculoviral IAP repeat (BIR) domains and often a RING-finger domain, that suppress cell suicide by inhibiting caspase function and activity (Deveraux and Reed 1999) . In Aedes species, IAP1 is perhaps the best characterized and has been investigated in vitro and in vivo (Blitvich et al. 2002 , Beck et al. 2007 , Li et al. 2007 ). In cell culture, Wang and Clem (2011) determined that an Ae. aegypti homolog (AaeIAP1) of the Drosophila caspase inhibitor DIAP, physically interacts with caspases such as AaeDronc, CASPS7, and CASPS8 and can block their activity. Also, AaeIAP1 can bind to IAP antagonists such as Michelob_x and IMP and inhibit IAP antagonist-induced caspase activation (Wang and Clem 2011) . In vivo work has found that IAP1 was expressed transcriptionally at all developmental stages of Ae. aegypti, with higher levels of IAP1 at the pupal and adult stages (Pridgeon et al. 2008b ). Additionally, IAP1 was expressed at higher levels at specific time intervals when Ae. aegypti mosquitoes were subjected to various temperatures, acetone or permethrin, and UV radiation.
RNAi studies have suggested that IAP1 might be a good target for applications in mosquito control. Researchers found that silencing IAP1 resulted in apoptosis in Ae. aegypti Aag-2 cells (Liu and Clem 2011, Pridgeon et al. 2011) . It has been reported that topically applying AaeIAP1 dsRNAs in acetone or a transfection reagent reduced expression levels and caused nearly 40% mortality in female adult mosquitoes (Pridgeon et al. 2008a) . Other reports assert that microinjection of dsRNA constructs against IAP1 resulted in substantial mortality in Ae. aegypti mosquitoes (Pridgeon et al. 2008a , Wang et al. 2012 , Ocampo et al. 2013 .
Because RNAi studies with IAP1 appear promising but have not been subsequently confirmed, our goals in this study were to perform a thorough reevaluation of AaeIAP1 and assess other IAPs for potential use in mosquito control. Here, we report the effects of IAP-silencing in Ae. aegypti utilizing dsRNAs (dsIAPs) against six known IAP targets. We first verify the specificity of the dsIAPs in Aag-2 cells. Additionally, we revisit topical application and microinjection of dsIAP1. To strengthen the conclusions about AaeIAP1, we expand these experiments into two other mosquito genera, Culex and Anopheles. We report the relative expression profiles of various IAP mRNAs in adult females over 9 d and after a bloodmeal. To our knowledge, this is the first published in vitro and in vivo study that examines and assesses other IAPs (besides IAP1) in Ae. aegypti, and evaluates IAP1 homologs in An. quadrimaculatus and Cx. quinquefasciatus as potential RNAi targets.
Materials and Methods

Mosquito Maintenance
Ae. aegypti (Orlando strain), An. quadrimaculatus, and Cx. quinquefasciatus were reared and maintained in the Center for Medical, Agricultural, and Veterinary Entomology (CMAVE) insectary using previously published procedures (Pridgeon et al. 2009 ). Colonies were kept at room temperature (RT, 22.5 C) or in an incubator (27 C) with a photoperiod of 14:10 (L:D) h with ad libitum access to 10% sucrose soaked cotton.
Expression Profiles
Cups of pupae were placed into screened cages and males were allowed to emerge. Two days later after most of the males had emerged, remaining pupae were put into another cage for emergence of (mostly) females. After an additional 24 h, cups were removed, and 10 females were collected as the 0-1 d postemergence sample. Similar collections were made daily through 9 d. Mosquitoes were frozen at À86 C before RNA extraction. These same time point collections were performed at least three times with a minimum of one week between experiments.
Samples were used (see Methods below) to derive expression profiles for AaeIAP1, 2, 5, 6, 9, and AaevIAF. We also assessed the expression of CquIAP1 and an IAP1 homolog in An. quadrimaculatus (AquIAP1) at the same time points. Accession numbers of transcripts are listed in Table 1 .
Bloodfeeding Studies in Ae. aegypti
Adult females 5-7 d postemergence were utilized to ensure that females were fully mature and adequately mated. Two hundred mosquitoes were placed into two 1 cu ft screened cages. One cohort was provided two 15-min exposures to a blood sausage of defibrinated bovine blood in cellulose casing, warmed by a 10-min exposure to 55 C water. Blood sausages were re-warmed between feedings to ensure most took a bloodmeal. Mosquitoes that did not bloodfeed were removed from the cage. The control cohort was only fed 10% sucrose.
Five females were collected at 0, 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 8, 10, 12, 15, 18, 21, 24, 30, 36, 42 , and 48 h after completion of bloodfeeding. Five mosquitoes from each cage were collected via mouth aspirator, cold anesthetized at À20 C for 3 min and then frozen at À86 C until RNA extraction. These collections were repeated three times from successive generations.
Synthesis of dsRNAs
Two dsRNA triggers, dsIAP1C (see Pridgeon et al. 2008a; 555 bps) and a green fluorescent protein dsRNA (dsGFP, 423 bps) were manufactured by Monsanto Company (St. Louis, MO). Eight other dsRNAs were made in the lab using the MegaScript Kit (Invitrogen, Carlsbad, CA) as described below. Sequence data (Table 2) were inputted into the RNAi design program provided by the German Cancer Center (http://www.dkfz.de/signaling/e-rnai3). Primers with appended T7 polymerase promoter sequences were used to create gene-specific amplicons that were 100-500 bps long (Table 2) .
Template PCR (94 C 2 min, 5 Â (94 C 30 s, 61 C 30 s, 72 C 1 min), 30 Â (94 C 30 s, 66 C 30 s, 72 C 1 min), 72 C 10 min) was done with a Mastercycler Gradient PCR Thermal Cycler (Eppendorf North America, Inc.; Hauppauge, NY) in 50-ml reactions. Reactions contained 0.4 ml Platinum Taq DNA Polymerase (5 U/ml), 5.0 ml of 10 Â PCR buffer (minus Mg), 1.5 ml of 50 mM MgCl 2 , 1.0 ml of 10 mM dNTP mix (Invitrogen, Carlsbad, CA), 2.0 ml of 10 mM of forward and reverse T7-appended primers (IDT, Coralville, IA), 39.1 ml of nuclease-free water (NFW), and 1 ml of cDNA template from Ae. aegypti, Cx. quinquefasciatus, and An. quadrimaculatus female mosquitoes. This initial PCR product was separated on a 2% TAE agarose gel. The product of the expected size was extracted with the Zymoclean Gel DNA Recovery Kit (Zymo Research Corporation; Irvine, CA) or QIAquick PCR Purification Kit (QIAGEN, Valencia, CA) and used for subsequent PCR reactions for further template amplification. Multiple additional reactions were prepared to generate sufficient template. After concentrating and washing twice with NFW in an Amicon Ultra-0.5 ml Centrifugal Filter Devices (10,000 NMWL; Millipore, Billerica, MA), templates were used for dsRNA production per the MegaScript instructions with input of 1ug of template per reaction and an extended transcription for 24 h at 37 C. After purification according to kit instructions, the resulting dsRNAs were concentrated with Amicon Ultra-0.5 ml Centrifugal Filter Devices, quantified using the NanoDrop 2000, and then frozen at À20 C for later use.
Cell Culture Studies
Ae. aegypti Aag-2 cells were cultured in Eagle's Modified Essential Medium (EMEM) w/L-Glutamine (ATCC, Manassas, VA) supplemented with 10% fetal bovine serum (FBS) in T75 flasks and maintained in a CO 2 Incubator, model 490 (Barnstead International, Dubuque, IA) at 27 C, 5.0% CO 2 .
For RNAi experiments, Aag-2 cells were plated in 24-well plates (Falcon, Becton Dickinson and Company; Franklin Lakes, NJ) subconfluently at 200,000 cells per well. Three days later, the media was removed from wells and replaced with 500 ml of fresh media containing one of the seven Ae. aegypti targeting dsRNAs (Table 2) at 100 mg/ml. Control cells were untreated or treated with dsGFP. Cell samples were collected after 1 d of dsRNA exposure, pelleted (1500-2000 rcf), washed twice with 500 ml of PBS, and frozen at À86 C for later RNA extraction.
Images of Aag-2 cells were captured at 20Â magnification using a Leica DMIL inverted microscope equipped with a Nikon DS-SI1 camera using NIS-Elements F v3.0 microscope imaging software. Table 1 for details. c All primers used have a T7 promoter sequence (TAATACGACTCACTATAGGG) included before the gene-specific portion of the primer. d Amplicon size does not include the contribution of the T7 promoter sequences that are not part of the final dsRNA. e Primers for dsIAP1 9074 production. f Primers for dsIAP1C production are taken from Pridgeon et al. (2008a) . The actual dsRNA used in this study was produced commercially based on this sequence.
Topical Application in Ae. aegypti Three-to five-day-old females were anesthetized at 4 C for 1 h. Ten mosquitoes were placed on their dorsal side on microscope slides and kept at 4 C until needed. A slide of mosquitoes was placed on a chill table (Model 1431, BioQuip; Rancho Dominquez, CA) and a droplet of 0.5 ml of acetone or dsRNA solution (i.e., dsGFP or dsIAP1C in acetone) was applied to the ventral surface of the mosquito's thorax using a Model 1702 series syringe with a blunt point and a PB600-1 repeating dispenser (Hamilton; Reno, NV). Solutions containing 94 ng of dsRNA per 0.5 ml were applied to 30 mosquitoes per experiment in three independent experiments. Groups of 15 were placed into 3.5 oz plastic screened cups (Solo TK35, Lake Forest, IL) with access to 10% sucrose-saturated cotton. Cups of mosquitoes were covered with plastic wrap, and placed in a 27 C incubator to allow mosquitoes to recover. Mortality was tracked for all cohorts at 3, 12, and 24 h postapplication (PA). One day PA, dead mosquitoes were removed and live mosquitoes were frozen at À86 C until RNA extraction. Roughly 10 mosquitoes were used for RNA extraction per cohort.
Mosquito Microinjections
Ae. aegypti Microinjections Adult female mosquitoes 3-7 d old were collected with an Insect Vac into a collecting chamber (BioQuip Products; Rancho Dominguez, CA), and then anesthetized on ice for roughly an hour. Ten anesthetized females were placed on their dorsal side and aligned on microscope slides to allow for easier injection. Slides with mosquitoes were kept at 4 C until needed for microinjection. Chilled slides were placed on a chill table and microinjected with the Nanoliter 2000 microinjection system (World Precision Instruments; Sarasota, FL). Needles were glass capillaries pulled on a Model 720 Vertical Pipette Puller (David Kopf Instruments, Tujunga, CA) at 16.8 resistance and a pull strength of 4. Pulled glass capillaries were then broken at the tip, to produce a sharp point.
Mosquitoes were microinjected in the mesokatepisternum with 0.01, 0.1, 1.0, or 2.0 mg of eight dsRNA triggers: dsGFP, dsIAP1C, dsIAP1 9074, dsIAP2, dsIAP5, dsIAP6, dsIAP9, and dsvIAF. Stock dsRNAs were diluted in NFW and 0.0033% Rhodamine B (for visualization of injected solution). Doses of 0.01, 0.1, and 1.0 mg were administered in 152 nl of solution, whereas 2.0 mg of dsRNA was delivered in 202.4 nl of solution.
Additionally, mosquitoes were also injected with 1.0 mg of siRNAs against AaeIAP1 (siIAP1A and siIAP1B) along with a siRNA negative control (siControl; siRNA noncomplementary to any known Ae. aegypti transcript). All siRNA were Ambion Silencer Select Custom Designed siRNA molecules (ThermoFisher Scientific, Waltham, MA), which have locked nucleic acids at the 3' overhangs. They were reconstituted with NFW to 5 mg/ml and delivered to mosquitoes in 202.4 nl.
Twenty-six mosquitoes were microinjected with each dsRNA or siRNA trigger per experiment in at least three independent experiments. Groups of 13 were placed into 3.5 oz plastic screened cups, inverted and placed over 10% sucrose-saturated cotton and left at RT to allow for recovery. Mortality was assessed for all cohorts at 1, 2, and 3 d postinjection (PI). At 2 and 3 d PI, live mosquito samples were frozen at À86 C until RNA extraction.
Microinjections in Cx. quinquefasciatus and An. quadrimaculatus Microinjections were performed using the same procedure as outlined above but with two modifications. First, a 30-s exposure to CO 2 from sublimated dry ice assisted in initial immobilization, after which they were maintained on ice. Injections were performed individually for these species rather than in groups of 10 on slides. All mosquitoes were injected with either dsGFP or species specific dsIAP1 (Table 2) . Two micrograms of dsRNA were delivered in 152 nl of solution.
RNA Extraction, cDNAs, and qPCR
Total RNA from frozen mosquitoes and cell pellets was isolated utilizing the Quick-RNA MiniPrep Kit (Zymo Research, Irvine, CA) and quantified on a NanoDrop 2000 (ThermoFisher Scientific, Waltham, MA). Complementary DNA was made via the AMV-RT Kit (Invitrogen, Carlsbad, CA) with oligo (dT) primers and 300 or 100 ng of RNA from mosquitoes or Aag-2 cells, respectively. Synthesis reactions were performed on the Mastercycler Gradient PCR Thermal Cycler using the suggested thermal profile.
Quantitative PCR was performed on an Applied Biosystems StepOnePlus using SYBR Select Master Mix (ThermoFisher Scientific, Waltham, MA). Reactions (30 ml) were prepared consisting typically of 15 ml of 2Â SYBR, 1.0 ml of template (cDNA), 12.0 ml of NFW, and 2.0 ml of 3 uM of combined forward and reverse primers. After thorough mixing, three technical replicates (10 ml each) were placed into 96-well PCR plates with a multichannel pipettor. For Ae. aegypti, L24 was used as the endogenous control based on previous studies that demonstrated its relatively constant expression (Pridgeon et al. 2009 , Choi et al. 2013 ). Determination of stable housekeeping genes for Cx. quinquefasciatus and An. quadrimaculatus was accomplished using BestKeeper Software v1.0 (http://www.gene-quantification.de/bestkeeper.html) to select among six possible reference gene candidates. For Cx. quinquefasciatus and An. quadrimaculatus, actin and an actin homolog were used as reference genes, respectively (Table 1) . Relative mRNA expression of test samples was determined using the comparative CT method (2 ÀDDCT method, Livak and Schmittgen 2001) .
Primers were designed with Primer3 (http://primer3.ut.ee/) using sequence data from NCBI and Vectorbase. Most default parameters were accepted; however, qPCR primers were designed with an optimal Tm of 60 C and an amplicon of 80-200 base pairs (bps) ( Table 1 ). Primers were manufactured by Integrated DNA Technologies (Coralville, IA). When possible, the amplicon for qPCR included an exon/exon boundary and did not include the same sequence targeted by dsRNA.
Statistical Analysis
Calculations and statistical analyses on qPCR data were performed in Microsoft Office Excel 2007 and SigmaPlot 13.0 (Systat Software Inc., San Jose, CA). For expression profiles, some data sets were transformed using the natural logarithm function. Statistical significance was determined via one-way ANOVA using transformed data from expression values represented in Fig. 1c and d .
Results
Expression Profiles of IAPs
We examined the relative mRNA expression of IAP1, IAP2, IAP5, IAP6, IAP9, and vIAF in Ae. aegypti adult females 0-9 d postemergence. Additionally, we assessed the relative IAP1 expression in Cx. quinquefasciatus (CquIAP1) and An. quadrimaculatus (AquIAP1) over time. Expression profiles from replicated experiments showed no significant differences in relative mRNA expression of AaeIAP1, AaeIAP6, AaevIAF, and CquIAP1 (Supp Fig. 1 [online  only] ). However, AaeIAP2 (P ¼ 0.026), AaeIAP5 (P ¼ 0.004), AaeIAP9 (P 0.001), and AquIAP1 (P 0.001) had significantly higher expression at later days when compared to 0-1 d (Fig. 1) .
Relative IAP expression was not significantly different at most time points through 48 h after a bloodmeal when compared to sugar fed controls. Although AaeIAP1 did have elevated mRNA expression at 48 h (P ¼ 0.048) and significantly lower expression at 0.75 (P ¼ 0.01) and 18 h postbloodmeal (P ¼ 0.039) in comparison to the control, no clear trend was observed ( Fig. 2a) . At 30 and 42 h, both AaeIAP2 (P ¼ 0.043, 30 h; P ¼ 0.029, 42 h) and AaeIAP5 (P ¼ 0.05, 30 h; P ¼ 0.005, 42 h) expression were elevated (Fig. 2b and c) with AaeIAP2 expression also significantly elevated 48 h after blood feeding (P ¼ 0.044). AaeIAP6 had the greatest number of time points (past 1.5 h) with significantly elevated mRNA expression. Compared to the controls, AaeIAP6 expression was significantly higher at time points 2 (P ¼ 0.037), 3 (P ¼ 0.018), 5 (P ¼ 0.027), 6 (P ¼ 0.003), 8 (P ¼ 0.036), 12 (P ¼ .007), 15 (P ¼ 0.007), 18 (P ¼ 0.024), 21 (P ¼ 0.017), and 24 (P ¼ 0.002) h after a bloodmeal (Fig. 2d ). Although the relative expression of AaeIAPs 2, 5, and 6, levels were slightly higher in blood-fed mosquitoes than non-bloodfed mosquitoes, none reached the level of statistical significance. No differences in expression were found for AaeIAP9 and AaevIAF for the 48 h after bloodfeeding although their mean values were generally higher than the controls (Supp Fig. 2 [online only] ).
Treatment of Ae. aegypti Aag-2 Cells With dsRNA
To ascertain whether the dsIAPs were effective in targeting their intended transcripts, Aag-2 cells were treated with dsIAPs and dsvIAF. Additionally, cells were treated with control GFP (dsGFP) or left untreated. One day after RNAi treatment, no morphological differences were observed for cells treated with dsIAPs 2, 5, 6, 9 and dsvIAF. These cells looked similar to the dsGFP treated and untreated controls (Fig. 3a) . Conversely, cells treated with dsIAP1 9074 or dsIAP1C, which both target the same transcript, had a discernible phenotype. Many cells were rounded and detached from the plate, which suggests that the cells may have lost their viability and were apoptotic (see Liu and Clem, 2011) (Fig. 3a) .
Cells treated with dsRNAs against IAP1, 2, 5, 6, and vIAF had significant knockdown (dsIAP1C, dsIAP1 9074, dsIAP2, dsIAP6, and dsvIAF, P 0.001; dsIAP5, P ¼ 0.004), suggesting that these dsRNAs were effectively reducing transcript levels of their intended targets ( Fig. 3b-g) . Triggers that targeted IAPs 1, 2, and vIAF were robustly silenced to less than 10% of control levels (IAP1, 0.02 and 0.05; IAP2, 0.08; vIAF, 0.02) in Aag-2 cells whereas dsIAP5 and dsIAP6 were less effectively silenced (IAP5, 0.29; IAP6, 0.52). However, we were unable to demonstrate knockdown in cells using dsIAP9. Cell lines from Cx. quinquefasciatus and An. quadrimaculatus were not available to test the IAP1 homologs from these species.
Topical Application of dsIAP1C
We attempted to replicate experiments detailed in an earlier report from this lab which emphasized that topical application of dsIAP1C resulted in significant death in Ae. aegypti mosquitoes as well as reduced IAP1 levels (Pridgeon et al. 2008a ). Instead of using the nontargeting dsRNA-Cun85 as a control, we used dsGFP. Ninety-four ng of dsGFP or dsIAP1C was applied to the ventral surface of the thorax. Mortality was recorded 3, 12, and 24 h PA and IAP1 expression was determined at 24 h PA. Results from three independent experiments suggested no significant reduction in either IAP1 expression or adult survivorship (Supp Table 1 
Silencing of IAPs by Microinjection
Although testing of Ae. aegypti dsRNAs in Aag-2 cells indicated trigger efficacy (with the exception of dsIAP9), the majority of these microinjections over a range of doses up to 2.0 mg did not yield significant knockdown at 2-3 d postinjection (PI). AaeIAP1 expression was knocked down with 1.0 mg of dsIAP1C at 2 d PI (0.72, P ¼ 0.017; Fig. 4a ), but not for 3 d PI (data not shown). AaeIAP1 expression was also not significantly reduced by dsIAP1 9074 at either 2 or 3 d PI. We subsequently tried microinjecting two siRNAs (siIAP1A and siIAP1B) that target AaeIAP1, including a siRNA negative control (siControl). However, we observed no significant reduction in AaeIAP1 expression at 2-3 d PI (Supp Fig. 4a [online  only] ). Moreover, we were unable to effectively and significantly lower CquIAP1 or AquIAP1 expression using species appropriate dsRNA against IAP1 (Supp Fig. 5a and c [online only] ). For all three species of mosquitoes, there were no statistically significant differences in mortality between controls or dsIAP1-injected mosquitoes (Fig. 6a; Supp Figs. 4b, 5b and d [online only] ).
We did observe statistically significant knockdown 2 d PI for AaeIAP2 at 0.1 mg (0.66, P ¼ 0.008; Fig. 4b) , and AaeIAP6 at 0.01 mg (0.43, P ¼ 0.037; Fig. 4c ). Whereas we were unable to detect IAP9-knockdown in mosquito-derived Aag-2 cells, we were able to gene-silence AaeIAP9 significantly in the whole mosquito with 0.01 mg of dsIAP9 (0.56 at 2 d PI, P ¼ .009; Fig. 4d ). No significant reduction in IAP expression was noted for AaeIAPs 2, 6, and 9 on the third day (data not shown). The dsRNA trigger that targeted AaevIAF appeared to be the most effective in the whole organism. Microinjection of 1.0 mg of dsvIAF into mosquitoes resulted in significant knockdown 2 d PI (0.62, P ¼ 0.014; Fig. 5a ), but not for 3 d (0.78, P ¼ 0.056; Fig. 5a ). Mosquitoes microinjected with 2.0 mg of dsvIAF had the greatest knockdown, with lowered vIAF expression of 0.19 and 0.40 at 2 and 3 d PI, respectively (P 0.001 and 0.009; Fig. 5b ). In fact, injection of dsvIAF at four different doses suggested dose-dependence as increasing dsRNA amounts caused greater knockdown (Fig. 5c ). Despite lowering IAP expression with dsIAPs 2, 9, and vIAF, mortalities were not different from controls (Fig. 6) . Mortalities between dsGFP-and dsIAP6-injected mosquitoes were not significant at 1 and 2 d PI, although statistical analysis suggested a difference on 3 d PI (P ¼ 0.047; Fig. 6c ).
Discussion
Of the six IAP-related genes examined in Ae. aegypti, half showed differential expression in adult females 0-9 d after emergence. Of those that demonstrated a difference in IAP expression (i.e., IAPs 2, 5, and 9), we found that some IAP expression was higher for older adult females when compared to the youngest ones (0-1 d). This was also true in An. quadrimaculatus. However, we found that there was no difference in AaeIAP1 expression in adults up to 9 d old, which is discordant with a previous study which showed elevated and differential expression of AeIAP1 transcript in adults at the Note that cells treated with dsIAP1C and dsIAP1 9074, two constructs that target IAP1, are rounded and many were detached from the plate. Cells treated with the remaining dsIAPs have a similar morphology to those treated with the control (dsGFP) and untreated. (b-g) Relative mRNA expression of IAPs in Aag-2 cells after treatment of dsIAPs for 1 d. Expression levels were relative to dsGFP-treated cells. n ¼ 3. Expression values were statistically determined using Student's t-test. Bars with asterisks are statistically different from control (**P < 0.001; *P < 0.05). Error bars represent standard deviation. same ages (see Table 2 in Pridgeon et al. 2008b) . A possible explanation for this discrepancy is the analysis method used in Pridgeon et al. (2008b) to calculate relative IAP1 expression which is very susceptible to variation in expression levels of the control transcript. We instead used the comparative DDC T method to ascertain relative IAP1 levels, which provides a better and more precise assessment of relative mRNA expression (Livak and Schmittgen 2001) .
Because previous studies have shown that expression levels of certain genes in adult female mosquitoes are significantly altered after blood feeding (Sanders et al. 2003 , Dana et al. 2005 , Thangamani and Wikel 2009 , Bonizzoni et al. 2011 ) and that IAP1 was differentially expressed and typically elevated in Ae. aegypti mosquitoes when exposed to certain stressors (Pridgeon et al. 2008b) , we expected that AaeIAP levels may be significantly altered and possibly elevated. Comparison of AaeIAP expression between control and blood-fed mosquitoes (up to 48 h postbloodmeal) showed that two-thirds of the IAPs had some differences in mRNA expression (at specific time intervals). Such differences for a minority of time points equated to significantly higher IAP transcript levels from blood-fed mosquitoes when compared to sugar fed at the same time points. Our results for AaeIAP1 were the exception. Although the expression level of AaeIAP1 was elevated 48 h postbloodmeal, the expression mean values of AaeIAP1 were generally lower than the controls for most of the time intervals, with AaeIAP1 being significantly down-regulated in blood-fed mosquitoes at two time points. Overall, for the majority of the time points, no statistical difference in IAP expression between blood-fed and non-blood-fed mosquitoes was observed for any of the IAPs examined. Our results that show reduced overall IAP1 expression after a bloodmeal confirm reports of expression patterns from RNA-Seq studies (Dissanyanke et al. 2010 , Bonizzoni et al. 2011 ). Interestingly, we noted an increase in expression by 48 h which was also observed in a previous study although they noted significance at 96 h (Dissanyanke et al. 2010) .
Excluding AaeIAP9, our in vitro findings clearly demonstrate that AaeIAPs 1, 2, 5, 6, and AaevIAF transcripts are sensitive to RNAi because they are significantly knocked down in cell culture. Gene expression analysis suggested that IAP9 expression in Aag-2 cells was extremely low and near the limit of detection, and thus, expression values that were obtained were highly variable and inconsistent. Because of the low presence of IAP9 in Aag-2 cells and our inability to get meaningful qPCR results, it precluded us from determining whether dsIAP9 silenced IAP9 expression in cell culture. Despite the other dsIAPs effectively reducing their intended IAP targets in Aag-2 cells, and with the exception of IAP1, no changes in morphology were observed. Although no apoptotic detection assays were performed, our data suggest that treatment of dsIAPs 2, 5, 6, and vIAF did not cause cell death in Aag-2 cells since they lacked the morphological hallmarks associated with apoptosis and appeared similar to the control dsGFP-treated and untreated cells (Fig. 3a) . Only cells treated with dsIAP1C (same construct used in Pridgeon et al. 2008) or dsIAP1 9074 against AaeIAP1 appeared apoptotic, which is consistent with earlier reports (Liu and Clem 2011, Pridgeon et al. 2011) . Based on a recent report, IAP6 is expressed predominantly in male mosquito tissues and would likely not cause apoptosis in Aag-2 cells since they are derived from embryonic tissue (Barletta et al. 2012 , Whyard et al. 2015 . Information on other mosquito IAPs is lacking, and like IAP6, may be expressed developmentally or in particular tissues, and therefore, may not be critical in a cell line or even the mature adult. Further, functional studies from several organisms have indicated that among the various IAPs, only some are effective in preventing apoptosis while others may function in cytokinesis (Ekert et al. 1999) This lab and others previously reported the efficacy of targeting IAP1 in Ae. aegypti mosquitoes which resulted in reduction of AaeIAP1 expression and mosquito survivorship (Pridgeon et al. 2008a , Wang et al. 2012 , Ocampo et al. 2013 . Accordingly, we sought to reproduce these earlier works as well as determine a dose response via microinjection and topical application. We observed no mortality or reduction in IAP1 expression upon topical application of dsIAP1C at a dose similar to that in Pridgeon et al. (2008a) . We also tried applying dsIAP1C topically at higher doses. Initially, we tried administering dsRNAs in acetone or TransIT -siQUEST at 4 mg/ml, which permits delivery of 2.0 mg per adult female (i.e., 0.5 ml applied per mosquito). Unexpectedly at this concentration, precipitation occurs. To counter this problem, we are currently investigating other carriers such as using non-ionic surfactants to administer dsRNAs. We did manage to knock down AaeIAP1 expression significantly at 1.0 mg in vivo; however, we were unsuccessful in determining a dose response via microinjection using dsIAP1C or dsIAP1 9074. Based on other studies that suggested RNA molecules of various sizes have differences in silencing efficiencies (Bolognesi et al. 2012 , Scott et al. 2013 , we later tried silencing AaeIAP1 by using siRNAs. Microinjection of siRNAs targeting AaeIAP1 was not effective (Supp Fig. 4 [online only] ). Interestingly, trigger size decreases from dsIAP1C to dsIAP1 9074 to siIAP1A and B. Whether the decrease in trigger size is a factor in the lack of knockdown is unclear.
We also tried another approach to induce death in Ae. aegypti mosquitoes based on a study which demonstrated that blood feeding after microinjection of dsRNAs resulted in substantial mortality (Isoe et al. 2011) . We injected dsvIAF, the dsRNA that yielded the greatest knockdown in vivo, and 3 d PI these mosquitoes were blood fed. Mortality was assessed 1-3 d postbloodmeal. Data from three independent experiments suggested that blood feeding after microinjection of dsvIAF did not induce mortality in adult females when compared to dsGFP-injected mosquitoes (data not shown).
In conclusion, despite confirming previous research on IAP1 targeting in vitro, administration of triggers against IAP1 by microinjection or topical application did not cause mortality. This disagrees with previous reports about IAP1 targeting in Ae. aegypti; therefore, we also tested triggers against CquIAP1 and AquIAP1 and obtained similar results. Whereas knockdown and disruption of IAP1 function in a number of other organisms is critical developmentally and does cause death (Wang et al. 1999 , Mané-Padr os et al. 2010 , Garbian et al. 2012 , Mills et al. 2015 , we found no real differences in mortality between control-and dsIAP1-injected mosquitoes at various doses and delivery methods. Moreover, knockdown of AaeIAPs 2, 6, 9, and vIAF via low or high doses of dsIAPs in vivo did not result in substantial mosquito death. Mortality percentages were low, and no statistically significant differences were found between cohorts. Given that silencing of most of the AaeIAPs did not induce apoptosis (except for IAP1) in vitro and that silencing by direct injection did not result in mosquito death in vivo, we suspect that IAPs may not be ideal RNAi targets in adult female mosquitoes. Other RNAi targets may show more promise in potentially controlling mosquito populations of Ae. aegypti, An. quadrimaculatus, and Cx. quinquefasciatus as has been found for other insect pests (Baum and Roberts 2014) . 
